Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters

Wako, Japan Clinical Trials

A listing of Wako, Japan clinical trials actively recruiting patients volunteers.

RESULTS

Found (4) clinical trials

Autologous Gene Therapy for Artemis-Deficient SCID

Children with SCID generally do not survive beyond the first year of life without definitive treatment. The most effective current cure is hematopoietic stem cell transplant (HCT) with a human leukocyte antigen (HLA) matched sibling. While a matched sibling HCT can successfully treat ART-SCID, fewer than 20% of affected children ...

Phase

1.38 miles

Learn More »

Mild Hypothermia and Acute Kidney Injury in Liver Transplantation

This study is a single-blinded, randomized controlled trial of mild hypothermia during liver transplantation to provide protection from AKI. Participants will be randomized to normothermia (36.5-37.5 C) versus mild hypothermia (34-35 C) during a portion of the liver transplant operation. The protocol is based on preliminary data from rodent models ...

Phase N/A

1.38 miles

Learn More »

A Study of Atezolizumab in Combination With Nab-Paclitaxel Compared With Placebo With Nab-Paclitaxel for Participants With Previously Untreated Metastatic Triple-Negative Breast Cancer (IMpassion130)

This multicenter, randomized, double-blind study will evaluate the efficacy, safety, and pharmacokinetics of atezolizumab (MPDL3280A) administered with nab-paclitaxel compared with placebo in combination with nab-paclitaxel in participants with locally advanced or metastatic triple-negative breast cancer (TNBC) who have not received prior systemic therapy for metastatic breast cancer (mBC). The safety ...

Phase

1.42 miles

Learn More »

Evaluation of NEUROCAP In the Treatment of Symptomatic Neuroma

Device description NEUROCAP, a bioresorbable nerve capping device based upon the NEUROLAC nerve guide, is indicated to protect a peripheral nerve end and to separate the nerve from surrounding environment to reduce the development of a symptomatic neuroma. NEUROCAP is composed of the same biocompatible, bioresorbable copolyester composing the NEUROLAC ...

Phase N/A

2.29 miles

Learn More »